A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT02880462

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The goal of the study is to investigate whether adding different doses of sulforaphane will benefit the clinical symptoms and cognitive function in individuals who have schizophrenia. This study will compare the sulforaphane with placebo. There is a thirty percent change (less than half) of receiving the placebo. The purpose of including placebo is to judge if the outcome is related to the study medication rather than other reasons.


Critère d'inclusion

  • Schizophrenia

Liens